Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Correlation of RET somatic mutations with clinicopathological features in sporadic medullary thyroid carcinomas.

British journal of cancer - 2 Jun 2009

Moura M M, Cavaco B M, Pinto A E, Domingues R, Santos J R, Cid M O, Bugalho M J, Leite V

Abstract excerpt

Screening of REarranged during Transfection (RET) gene mutations has been carried out in different series of sporadic medullary thyroid carcinomas (MTC). RET-positive tumours seem to be associated to a worse clinical outcome. However, the correlation between the type of RET mutation and the patients' clinicopathological data has not been evaluated yet. We analysed RET exons 5, 8, 10-16 in fifty-one sporadic MTC,...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aged
Share to Aged, 80 and over

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to RET gene

Share to Mutation

Share to Prognosis

Share to Proto-Oncogene Proteins c-ret

Share to Thyroid Cancer Diagnosis and Treatment

Share to Thyroid Neoplasms

Source

Open in PubMed Open full text

Identifiers

PMID: 19401695
DOI: 10.1038/sj.bjc.6605056
PMCID: PMC2695700

Genes

RET

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Correlation of RET somatic mutations with clinicopathological features in sporadic medullary thyroid carcinomas.PMID 19401695Read ↗

Somatic mutations in the RET proto-oncogene in sporadic medullary thyroid carcinomas.Semantic proximity Read ↗

Somatic mutations in RET exons 12 and 15 in sporadic medullary thyroid carcinomas: different spectrum of mutations in sporadic type from hereditary type.Semantic proximity Read ↗

A cohort study on 10-year survival of sporadic medullary thyroid carcinoma with somatic RET mutation.Semantic proximity Read ↗

Prognostic significance of somatic RET oncogene mutations in sporadic medullary thyroid cancer: a 10-year follow-up study.Semantic proximity Read ↗

Predominant RET Germline Mutations in Exons 10, 11, and 16 in Iranian Patients with Hereditary Medullary Thyroid CarcinomaSemantic proximity Read ↗

RET genetic screening of sporadic medullary thyroid cancer (MTC) allows the preclinical diagnosis of unsuspected gene carriers and the identification of a relevant percentage of hidden familial MTC (FMTC)Semantic proximity Read ↗

Three novel mutations in the RET proto-oncogene.Semantic proximity Read ↗

Mutation of the RET protooncogene in sporadic medullary thyroid carcinoma.Semantic proximity Read ↗

Identification of a novel point mutation in the RET gene (Ala883Thr), which is associated with medullary thyroid carcinoma phenotype only in homozygous condition.Semantic proximity Read ↗

RET protooncogene mutations in patients with apparently sporadic medullary thyroid carcinoma.Semantic proximity Read ↗

[Proto-oncogene RET somatic mutations in medullary thyroid carcinoma].Semantic proximity Read ↗

Clinical significance of RET and RAS mutations in sporadic medullary thyroid carcinoma: a meta-analysis.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.